All patients involved in the phase 1 trial of a personalized cancer vaccine for high-risk stage III/IV kidney cancer showed a ...

A new personalized cancer vaccine has shown encouraging results in preventing the return of kidney cancer after surgery.

Dana-Farber Cancer Institute researchers report that all nine patients in a clinical trial being treated for stage III or IV ...

Patients with advanced kidney cancer who received an experimental vaccine after their tumors were removed were still ...

Dana-Farber Cancer Institute researchers report that all nine patients in a clinical trial being treated for stage III or IV clear cell renal cell carcinoma (a form of kidney cancer), generated a ...

Cancer researchers are one step closer to developing an effective vaccine to treat people with clear cell renal cell ...

In a small clinical trial of nine patients with stage III and IV kidney cancer, a personalized anti-tumor vaccine generated ...

After their advanced kidney tumors were surgically removed, nine patients were protected from the cancer returning thanks to ...

A phase 1 trial of a personalized cancer vaccine for stage III/IV clear cell renal cell carcinoma showed promising results.

The advent of vaccinations came when a scientist, by the name of Edward Jenner, discovered that an individual exposed to a ...

A personalized vaccine against advanced kidney cancer has shown encouraging results in a clinical trial, with all nine ...